Davare, M. A. (2018). Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationDavare, M. A. Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions Are Targetable Oncogenes in Glioma. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationDavare, M. A. Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions Are Targetable Oncogenes in Glioma. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.